Human papillomavirus (HPV) infections account for over 600,000 new cancer cases every
year [1]. HPV is implicated in approximately 70% of oropharyngeal cancers (OPCs), 90% of …

BACKGROUND Mixed lineage kinase domain‐like protein (MLKL) is a necrosome component
mediating programmed necrosis that may be an important determinant of cancer cell …

Diversity of the gut microbiome is associated with higher response rates for cancer patients
receiving immunotherapy but has not been investigated in patients receiving radiation …

Tumor microbiota can produce active metabolites that affect cancer and immune cell signaling,
metabolism, and proliferation. Here, we explore tumor and gut microbiome features that …

Purpose As brachytherapy utilization rates decline, we sought to evaluate the state of
brachytherapy training during radiation oncology residency. Methods and Materials US radiation …

Objectives The aim of this study was to characterize variation in the gut microbiome of women
with locally advanced cervical cancer and compare it to healthy controls. Methods We …

In multiple anatomic sites, patients with cancers associated with the Human Papillomavirus (HPV)
experience better locoregional control and overall survival after radiotherapy and/or …

Background Bilobar colorectal liver metastases (CRLM), are now aggressively managed in
a multidisciplinary fashion with a two-stage hepatectomy; however, up to 30% of patients are …

Purpose Patients receiving pelvic radiation for cervical cancer experience high rates of acute
gastrointestinal (GI) toxicity. The association of changes in the gut microbiome with bowel …

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with poor outcomes
with current therapies. Gemcitabine is the primary adjuvant drug used clinically, but its …